These observations clearly indicate involvement of IGFBP-3 in CVD, obesity and insulin resistance; however the mechanisms responsible for the role of IGFBP-3 in metabolic syndrome remains poorly understood. This evidence concerns the gene IGFBP3 and obesity due to melanocortin 4 receptor deficiency.